Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium

Prostate

Volumn 73, Issue 5, 2013, Pages 476-488

  Pruitt, Freddie L ^a   He, Yue ^a   Franco, Omar E ^b   Jiang, Ming ^b   Cates, Justin M ^b   Hayward, Simon W ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

cathepsin D; prostate cancer; stromal epithelial interactions

Indexed keywords

CATHEPSIN D; CYCLIN D1; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; EMBRYO; FETUS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RAT; STROMA CELL; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD1; CATHEPSIN D; CELL LINE; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PARACRINE COMMUNICATION; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; STROMAL CELLS; UP-REGULATION;

EID: 84875126913     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22589     Document Type: Article

References (49)

1. Weinberg RA,. Coevolution in the tumor microenvironment. Nat Genet 2008; 40: 494-495.
2. Li H, Fan X,. Tumor microenvironment: The role of the tumor stroma in cancer. J Cell Biochem 2007; 101: 805-815.
3. Cunha G,. Tissue interactions between epithelium and mesenchyme of urogenital and integumental origin. Anat Rec 1972; 172: 529-541.
4. Olumi A, Grossfeld G, Hayward S, Carroll P,. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002-5011.
5. Cunha GR, Hayward SW, Wang YZ,. Role of stroma in carcinogenesis of the prostate. Differentiation 2002; 70: 473-485.
6. Grossfeld G, Hayward S, Tlsty T,. The role of stroma in prostatic carcinogenesis. Endocr Relat Cancer 1998; 5: 253-270.
7. Joesting M, Perrin S, Elenbaas B, Fawell S,. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res 2005; 65: 10423-10430.
8. Ao M, Franco O, Park D, Raman D, Williams K,. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 2007; 67: 4244-4253.
9. He Y, Franco OE, Jiang M, Williams K, Love HD, Coleman IM, Nelson PS, Hayward SW,. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression. Cancer Res 2007; 67: 8188-8197.
10. Franco OE, Jiang M, Strand DW, Peacock J, Fernandez S, Jackson RS, Revelo MP, Bhowmick NA, Hayward SW,. Altered TGF-signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res 2011; 71: 1272-1281.
11. Orr B, Vanpoucke G, Grace O, Smith L,. Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia. Prostate 2011; 71: 305-317.
12. Orr B, Riddick A, Stewart G, Anderson R,. Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate. Oncogene 2012; 31: 1130-1142.
13. Vanpoucke G, Orr B, Grace C, Chan R, Ashley GR, Williams K, Franco OE, Hayward SW, Thomson AA,. Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease. Genome Biol 2007; 8: R213.
14. Bhowmick NA, Neilson EG, Moses HL,. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-337.
15. Cheng N, Bhowmick N, Chytil A, Gorksa A,. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 2005; 24: 5053-5068.
16. MacDougall J,. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995; 14: 351-362.
17. McCawley L,. Matrix metalloproteinases: They're not just for matrix anymore. Curr Opin Cell Biol 2001; 13: 534-540.
18. Tuxhorn J, Ayala G,. Reactive stroma in prostate cancer progression. J Urol 2001; 166: 2472-2483.
19. Egberts F, Heinrich M, Jensen J,. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation. J Cell Sci 2004; 117: 2295-2307.
20. Guicciardi M, Leist M,. Lysosomes in cell death. Oncogene 2004; 23: 2881-2890.
21. Chen S, Arany I, Apisarnthanarax N,. Response of keratinocytes from normal and psoriatic epidermis to interferon-γ differs in the expression of zinc-α2-glycoprotein and cathepsin D. FASEB J 2000; 14: 565-571.
22. Laurent-Matha V,. Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J Cell Biol 2005; 168: 489-499.
23. Hara I, Miyake H, Yamanaka K, Hara S,. Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression. Oncol Rep 2002; 9: 1379-1383.
24. Rochefort H, Garcia M, Glondu M, Laurent V,. Cathepsin D in breast cancer: Mechanisms and clinical applications, a 1999 overview. Clin Chim Acta 2000; 291: 157-170.
25. Vetvicka V, Vetvickova J,. Effect of procathepsin D and its activation peptide on prostate cancer cells. Cancer Lett 1998; 129: 55-59.
26. Konno S, Cherry JP, Mordente JA, Chapman JR, Choudhury MS, Mallouh C, Tazaki H,. Role of cathepsin D in prostatic cancer cell growth and its regulation by brefeldin A. World J Urol 2001; 19: 234-239.
27. Morikawa W, Yamamoto K, Ishikawa S, Takemoto S, Ono M, Fukushi JI, Naito S, Nozaki C, Iwanaga S, Kuwano M,. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J Biol Chem 2000; 275: 38912-38920.
28. Tsukuba T, Okamoto K, Yasuda Y, Morikawa W, Nakanishi H, Yamamoto K,. New functional aspects of cathepsin D and cathepsin E. Mol Cells 2000; 10: 601-611.
29. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P,. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 1995; 31: 14-24.
30. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR,. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001; 61: 8135-8142.
31. Williams K, Fernandez S, Stien X, Ishii K, Love HD, Lau Y-FC, Roberts RL, Hayward SW,. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate 2005; 63: 369-384.
32. Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier H-UG, Dahiya R, Cunha GR,. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 1998; 63: 131-140.
33. Hayward SW, Haughney PC, Lopes ES, Danielpour D, Cunha GR,. The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment. Prostate 1999; 39: 205-212.
34. Reid WA, McGechaen K, Branch T, Gray HD, Thompson WD, Kay J,. Immunolocalisation of aspartic proteinases in the developing human stomach. J Dev Physiol 1989; 11: 299-303.
35. Weidner N, Folkman J, Pozza F,. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-1887.
36. Glondu M, Liaudet-Coopman E, Derocq D, Platet N, Rochefort H, Garcia M,. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene 2002; 21: 5127-5134.
37. Nomura T, Katunuma N,. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005; 52: 1-9.
38. Shen J, Person M, Zhu J, Abbruzzese J,. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004; 64: 9018-9026.
39. Tumminello FM, Leto G, Pizzolanti G, Candiloro V, Crescimanno M, Crosta L, Flandina C, Montalto G, Soresi M, Carroccio A, Bascone F, Ruggeri I, Ippolito S, Gebbia N,. Cathepsin D, B and L circulating levels as prognostic markers of malignant progression. Anticancer Res 1996; 16: 2315-2319.
40. Nadji M, Fresno M, Nassiri M, Conner G,. Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer. Hum Pathol 1996; 27: 890-895.
41. Bacac M, Provero P, Mayran N, Stehle J-C, Fusco C, Stamenkovic I,. A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival. PLoS ONE 2006; 1: e32.
42. Neuman E, Ladha M, Lin N,. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 1997; 17: 5338-5347.
43. Lyons RM, Keski-Oja J, Moses HL,. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 1988; 106: 1659-1665.
44. Phillips JL, Hayward SW, Wang Y, Vasselli J, Pavlovich C, Padilla-Nash H, Pezullo JR, Ghadimi BM, Grossfeld GD, Rivera A, Linehan WM, Cunha GR, Ried T,. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 2001; 61: 8143-8149.
45. Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF,. Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res 2001; 7: 2984-2997.
46. Ling V,. Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997; 40: S3-S8.
47. Pérez-Tomás R,. Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 2006; 13: 1859-1876.
48. Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG,. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008; 40: 650-655.
49. Allinen M, Beroukhim R, Cai L, Brennan C,. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17-32.